Skip links and keyboard navigation

Medicinal cannabis products

Current Commonwealth and State regulations are designed to ensure the supply of medicinal cannabis is safe, and to protect and help patients.

Doctors must have confidence that any substance they prescribe to help treat a patient is safe. Doctors and their patients need to know that any medical product used for treatment has a predictable and reliable effect. Users of medicinal cannabis products deserve the same certainty.

Accessing a legal product

Medicinal cannabis use is only lawful when the cultivation, manufacture, prescribing and supply complies with all applicable Commonwealth and state or territory laws. Over time, the medicinal cannabis supply will be easier to access and the cost of legal products should reduce.

Access to Nabiximols (Sativex) in Queensland

Sativex is currently the only medicinal cannabis product registered in the Australian Register of Therapeutic Goods (ARTG)—it is registered for use in spasticity associated with Multiple Sclerosis (Australia). In some other countries it is used for the management of advanced cancer pain e.g. Canada.

In Queensland, all doctors are able to prescribe Sativex without requiring an approval.

More information about medicinal cannabis products is available on the Office of Drug Control’s website. This website also provides contact details for sponsors of medicinal cannabis products.

Last updated: 23 June 2020